Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23374 | 293 | 33.8 | 60% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3047 | 1955 | STEREOLOGY//DISECTOR//CAVALIERI ESTIMATOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MICROMINIPIG | Author keyword | 24 | 91% | 3% | 10 |
2 | RETHINK | Author keyword | 7 | 64% | 2% | 7 |
3 | VET HISTOPATHOL | Address | 6 | 47% | 3% | 9 |
4 | DOMEST ANIM INTERNAL MED | Address | 4 | 67% | 1% | 4 |
5 | MINIPIG | Author keyword | 4 | 14% | 9% | 25 |
6 | YUCATAN MICROPIG | Author keyword | 3 | 50% | 1% | 4 |
7 | SECT SAFETY MED TERATOL | Address | 3 | 60% | 1% | 3 |
8 | GOTTINGEN MINIPIGS | Author keyword | 3 | 42% | 2% | 5 |
9 | BETA CELL REDUCTION | Author keyword | 2 | 67% | 1% | 2 |
10 | YUCATAN PIG | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MICROMINIPIG | 24 | 91% | 3% | 10 | Search MICROMINIPIG | Search MICROMINIPIG |
2 | RETHINK | 7 | 64% | 2% | 7 | Search RETHINK | Search RETHINK |
3 | MINIPIG | 4 | 14% | 9% | 25 | Search MINIPIG | Search MINIPIG |
4 | YUCATAN MICROPIG | 3 | 50% | 1% | 4 | Search YUCATAN+MICROPIG | Search YUCATAN+MICROPIG |
5 | GOTTINGEN MINIPIGS | 3 | 42% | 2% | 5 | Search GOTTINGEN+MINIPIGS | Search GOTTINGEN+MINIPIGS |
6 | BETA CELL REDUCTION | 2 | 67% | 1% | 2 | Search BETA+CELL+REDUCTION | Search BETA+CELL+REDUCTION |
7 | YUCATAN PIG | 2 | 67% | 1% | 2 | Search YUCATAN+PIG | Search YUCATAN+PIG |
8 | DIABETOGENIC DIET | 1 | 40% | 1% | 2 | Search DIABETOGENIC+DIET | Search DIABETOGENIC+DIET |
9 | MINI PIGS | 1 | 25% | 1% | 3 | Search MINI+PIGS | Search MINI+PIGS |
10 | GOTTINGEN MINIPIG | 1 | 15% | 2% | 5 | Search GOTTINGEN+MINIPIG | Search GOTTINGEN+MINIPIG |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLINICAL CHEMICAL VALUES | 18 | 89% | 3% | 8 |
2 | YUCATAN MINIATURE SWINE | 4 | 47% | 2% | 7 |
3 | GOTTINGEN MINIPIG | 4 | 28% | 4% | 13 |
4 | GOTTINGEN MINIPIGS | 3 | 38% | 2% | 6 |
5 | DIABETIC DYSLIPIDEMIC PIGS | 1 | 50% | 1% | 2 |
6 | MODERATE INSULIN DEFICIENCY | 1 | 50% | 1% | 2 |
7 | MONOSODIUM GLUTAMATE METABOLISM | 1 | 100% | 1% | 2 |
8 | OBESE PIGS | 1 | 30% | 1% | 3 |
9 | OSSABAW MINIATURE SWINE | 1 | 21% | 1% | 3 |
10 | MINIPIG | 1 | 13% | 2% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Microminipig, a Non-rodent Experimental Animal Optimized for Life Science Research: Preface | 2011 | 11 | 4 | 100% |
Porcine Models of Accelerated Coronary Atherosclerosis: Role of Diabetes Mellitus and Hypercholesterolemia | 2013 | 5 | 27 | 26% |
Microminipig, a Non-rodent Experimental Animal Optimized for Life Science Research: Novel Atherosclerosis Model Induced by High Fat and Cholesterol Diet | 2011 | 15 | 30 | 23% |
Genetically engineered pig models for diabetes research | 2014 | 3 | 60 | 10% |
Swine models of type 2 diabetes mellitus: Insulin resistance, glucose tolerance, and cardiovascular complications | 2006 | 61 | 87 | 25% |
Use of the Gottingen minipig as a model of diabetes, with special focus on type 1 diabetes research | 2004 | 89 | 125 | 21% |
Neonatal animal testing paradigms and their suitability for testing infant formula | 2013 | 6 | 47 | 4% |
Swine as a Model of Experimental Atherosclerosis | 2011 | 0 | 24 | 13% |
Use of nontraditional animals for evaluation of pharmaceutical products | 2006 | 17 | 24 | 8% |
ANTICANCER DRUG SCREENING AND DISCOVERY IN THE 1990S - A EUROPEAN PERSPECTIVE | 1993 | 13 | 81 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VET HISTOPATHOL | 6 | 47% | 3.1% | 9 |
2 | DOMEST ANIM INTERNAL MED | 4 | 67% | 1.4% | 4 |
3 | SECT SAFETY MED TERATOL | 3 | 60% | 1.0% | 3 |
4 | DISCOVERY MANAGEMENT | 2 | 50% | 1.0% | 3 |
5 | ASSAY CELL TECHNOL | 2 | 23% | 2.4% | 7 |
6 | DIABET CARDIOVASC BIOL PROGRAM | 1 | 21% | 1.0% | 3 |
7 | CNS DISCOVERY PSYCHIAT | 1 | 50% | 0.3% | 1 |
8 | GLP OBES PHARMACOL 1 | 1 | 50% | 0.3% | 1 |
9 | MED 2ND | 1 | 50% | 0.3% | 1 |
10 | SECT SUSTAINABLE BIOTECH | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228576 | PHARMACOKINET BIOANAL//CYP2D19//PROPRANOLOL ENANTIOMER |
2 | 0.0000208074 | SAN DIEGO MICROSURG//CHRONIC BLOOD SAMPLING//CHRONIC INTRAVENOUS INFUSION |
3 | 0.0000176862 | INTERVAL SPRINT TRAINING//DIABET CARDIOVASC HLTH//DIABET CARDIOVASC BIOL PROGRAM |
4 | 0.0000156009 | EXPT NEUROSCI CENSE//GOTTINGEN MINIPIG//STEREOTAXIC INSTRUMENT |
5 | 0.0000077642 | HIGH PHOSPHORUS DIET//KIDNEY CALCIFICATION//KIDNEY MINERAL CONCENTRATION |
6 | 0.0000070247 | IRON STORAGE DISEASE//BLACK RHINOCEROS//DICEROS BICORNIS |
7 | 0.0000067462 | SWINE LEUKOCYTE ANTIGEN//MELIM//SWINE LEUKOCYTE ANTIGENS |
8 | 0.0000064018 | SPLAYLEG//CONGENITAL SPLAY LEG//DUPLICATION OF RECTUM |
9 | 0.0000063571 | DIABETES INDUCTION//ALAMOGORDO PRIMATE IL//WINCON |
10 | 0.0000055985 | TGN1412//SAFETY PHARMACOLOGY//REPEAT DOSE TOXICITY STUDIES |